EN DE
Watch VT GMP Co.Ltd for free: we tell you when fair value or trend changes.
Data-driven stock valuation

VT GMP Co.Ltd (018290) fair value: what the stock is really worth

As of Nov 11, 2026: fair value (intrinsic value) of VT GMP Co.Ltd stock KRW 28,218, price KRW 9,970, upside +183.0%, quality 66 out of 100. Rating: strongly undervalued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Industrials KR · ISIN KR7018290007

VG VT GMP Co.Ltd logo Some data Nov 12, 2026

VT GMP Co.Ltd

018290 · KQ
Undervalued, but in a downtrend

The stock costs 65% less than our calculation considers fair.

Fair value 28,218 KRW · Strongly undervalued
Quality 66/100
Low debt
Generates free cash flow
Ranks above peers (13/13)
Even on cautious assumptions the value is 89% above the price (18,816 KRW).
Mixed Growth (revenue 5y +32.4 %/yr in KRW)
Thin margins · 8.3% net margin (TTM)
Moderate moat 59/100 · thin data
Some data
Watch VT GMP Co.Ltd for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

44,400 KRW 4,765 KRW Fair Value 28,218 KRW Jun 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 12, 2026.

How to read this chart

60‑month range 4,765 KRW – 44,400 KRW · fair‑value band 18,816 KRW – 46,168 KRW · the 9,970 KRW price screens below the 28,218 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 12, 2026.

Follow VT GMP Co.Ltd in your weekly email

Every Wednesday you see whether VT GMP Co.Ltd is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

VT Co., Ltd. engages in the manufacture and distribution of cosmetics in South Korea and internationally. It also offers lithium sulfur batteries and electrode structure manufacturing devices; and hydrogen energy solutions, as well as laminating business.

Show moreShow less

The company was formerly known as VT GMP Co.,Ltd. and changed its name to VT Co., Ltd. in July 2023. VT Co., Ltd. was founded in 1986 and is headquartered in Paju-si, South Korea.

Stock analysis

VT GMP Co.Ltd (018290) currently trades at 9,970 KRW, while our model-based Fair Value estimate is 28,218 KRW, implying the stock looks roughly 65% undervalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of 42,870 KRW per share, and 23 of the 24 models we run sit above the 9,970 KRW price.

Bear case: the Asset-Based group reads lowest at 2,936 KRW, and 1 of the 24 models stay below the price. Data coverage for this calculation is medium.

Scenario range: 18,816 KRW (bear) to 46,168 KRW (bull), the price of 9,970 KRW sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 66/100 (solid quality), in the Industrials sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

VT GMP Co.Ltd reported revenue of 437B KRW in FY2025 versus 227B KRW in FY2021, a compound +17.8%/yr. Reported net income was 60.9B KRW in FY2025, compounding +42.2%/yr from FY2021.

Key figures

Market cap 351B KRW (≈ $264M) Micro · P/E ratio 8.8 · P/S ratio 0.75 · EPS (TTM) 1,129 KRW · Net margin 8.3% · Return on equity 14.9% · Return on assets (EBIT) 18.7% (5-year average) · Operating margin 8.1%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 59 out of 100 (low confidence).

What moves the price

The share trades about 58% below its 52-week high and 3% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Industrials peers we cover trades at −13% fair-value upside, at 183%, 018290 screens cheaper than that median.

Fair Value models

Bear 18,816 KRW Fair Value 28,218 KRW Bull 46,168 KRW
Price 9,970 KRW · Upside +183.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (977.11 KRW per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF 18,016 KRW 26,837 KRW 48,829 KRW 78
Growth DCF 17,260 KRW 28,218 KRW 46,168 KRW 77
EPV 18,581 KRW 20,693 KRW 22,432 KRW 74
All 24 models by family
DCF Models
FCF DCF 18,016 KRW 26,837 KRW 48,829 KRW 78
Owner Earnings 22,560 KRW 42,511 KRW 77,826 KRW 73
5Y Revenue Exit 16,483 KRW 28,214 KRW 49,074 KRW 70
5Y EBITDA Exit 19,598 KRW 35,040 KRW 60,853 KRW 72
5Y P/E Exit 21,572 KRW 41,614 KRW 67,018 KRW 69
10Y Revenue Exit 16,375 KRW 28,930 KRW 45,068 KRW 65
10Y EBITDA Exit 18,731 KRW 34,024 KRW 60,968 KRW 65
10Y P/E Exit 19,958 KRW 37,251 KRW 66,156 KRW 61
Earnings-Based
Graham-Dodd 11,963 KRW 80,605 KRW 112,951 KRW 63
Lynch FV 23,619 KRW 33,742 KRW 43,865 KRW 61
PEG = 1.0 23,619 KRW 33,742 KRW 43,865 KRW 57
EPV 18,581 KRW 20,693 KRW 22,432 KRW 74
Multiples
P/E Multiple 22,430 KRW 29,907 KRW 37,384 KRW 63
P/S Multiple 14,200 KRW 18,933 KRW 23,666 KRW 58
P/B Multiple 11,255 KRW 15,006 KRW 18,758 KRW 55
EV/EBIT 24,700 KRW 33,074 KRW 41,448 KRW 66
EV/EBITDA 18,816 KRW 25,229 KRW 31,641 KRW 67
EV/Revenue 12,832 KRW 18,512 KRW 24,192 KRW 53
Asset-Based
NCAV (Graham) 1,937 KRW 2,936 KRW 3,669 KRW 54
Growth DCF
Growth DCF 17,260 KRW 28,218 KRW 46,168 KRW 77
Rev-Margin DCF 16,483 KRW 29,117 KRW 47,657 KRW 71
Economic Profit
Residual Income 9,366 KRW 13,025 KRW 23,616 KRW 67
ROIC Compounder 20,946 KRW 26,140 KRW 32,273 KRW 72
Growth Earnings
Growth-Adj P/E 30,009 KRW 42,870 KRW 55,731 KRW 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 66/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 88
How much profit the company makes from its sales and capital
Quality Growth 38
Are margins and returns getting better?
Cashflow 53
Do the profits arrive as real cash?
Financial strength 94
Debt, balance sheet and risk of trouble
Investment 38
Does it invest with discipline instead of growing at any price?
Low Volatility 53
How calm the share price moves, does not count
Price momentum 6
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 1
Distance to the 52-week high, does not count
New shares 80
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 87/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+1.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+22.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+32.4%
Start year 2020 (pandemic). Over 10 years: +25.0% a year
Revenue growth 14 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.4%
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
≈ +81.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year+81.3%
Dividend (yield on the price)0.0%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.5% → 19%
⚠ Approximate: the rate leans on 2025, which sits 131% above its own trend.

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−7.6%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about −9.5% a year for the price.

Watch 018290, get fair value alerts →

Compare VT GMP Co.Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Business Equipment & Supplies · 78 stocks

Beats the industry median on 13/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 66 · Top 25%
Fair Value upside +183.0% · Top 25%
Profitability
Return on equity (12 months) 14.9% · Top 25%
Return on assets 17.2% · Top 25%
Net margin (12 months) 8.3% · Above median
Operating margin (12 months) 8.1% · Above median
Growth and dividend
Revenue growth (quarter YoY) 18.1% · Top 25%
Balance sheet
Debt / equity 0.03× · Below median

Valuation Multiplesvs Business Equipment & Supplies median · lower = cheaper

P/E (12 months) 8.8× · Cheapest 25%
P/B 1.45× · Cheaper than median
P/S (12 months) 0.75× · Cheaper than median
Price / free cash flow (fiscal year) 7.8× · Cheaper than median
EV/EBITDA 4.6× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 28
FUTURE (revenue growth)91 · sector 16
PAST (return on equity)60 · sector 29
HEALTH (low debt)98 · sector 98
DIVIDEND (yield)0 · sector 51

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Business Equipment & Supplies stocks, each showing price versus our Fair Value estimate.

Explore undervalued stocks

More undervalued Industrials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

VT GMP Co.Ltd: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "VT GMP Co.Ltd Fair Value". https://www.fairvalue-calculator.com/stock/018290

Frequently asked questions

Is VT GMP Co.Ltd (018290) overvalued or undervalued?
As of Nov 12, 2026, our model estimates a fair value of 28,218 KRW versus a price of 9,970 KRW, about +183% upside (undervalued).
What is the fair value of 018290?
Our model-based fair value for VT GMP Co.Ltd is 28,218 KRW (as of Nov 12, 2026), built from audited fundamentals. The current price: 9,970 KRW.
What is the quality score of 018290?
VT GMP Co.Ltd has a Quality Score of 66/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for VT GMP Co.Ltd (018290)?
Our model-based price target is the fair value of 28,218 KRW (as of Nov 12, 2026) from 24 valuation models. Cautious scenario 18,816 KRW, optimistic scenario 46,168 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the VT GMP Co.Ltd stock forecast for 2026?
Our models put fair value at 28,218 KRW, about +183% upside versus a price of 9,970 KRW (undervalued). Cautious scenario 18,816 KRW, optimistic scenario 46,168 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of VT GMP Co.Ltd (018290)?
VT GMP Co.Ltd reported trailing-twelve-month revenue of about 471B KRW (latest available figure, as of Nov 12, 2026).
What growth is priced into VT GMP Co.Ltd (018290)?
For today's price to be fair in a discounted-cash-flow model, VT GMP Co.Ltd would have to grow free cash flow by -7.6 % per year for five years (discount rate 11.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +32.4 % per year. As of Nov 12, 2026.
What discount rate (WACC) does the fair value of 018290 use?
Our models discount VT GMP Co.Ltd at 11.6 %: a base by market capitalisation (micro), damped by beta 0.11, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For VT GMP Co.Ltd that is -7.6 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (11.6 %) and the same formula as our fair value.
How much growth has VT GMP Co.Ltd (018290) delivered so far?
Over the past 5 years revenue at VT GMP Co.Ltd grew +32.4 % a year. The price currently implies free-cash-flow growth of -7.6 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of VT GMP Co.Ltd (018290) growing?
The median revenue growth in the sector is +8.7 % a year. That is the yardstick for the growth priced into VT GMP Co.Ltd (-7.6 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of VT GMP Co.Ltd (018290)?
The free-cash-flow yield on the price is 13.02 %: that much free cash flow VT GMP Co.Ltd produces per unit of market value. When it exceeds the discount rate of our models (11.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of VT GMP Co.Ltd (018290)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For VT GMP Co.Ltd it is 28,218 KRW per share (as of Nov 12, 2026), against a price of 9,970 KRW. It is the blended result of 24 valuation models in 7 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is VT GMP Co.Ltd stock overvalued or undervalued in 2026?
As of Nov 12, 2026, 018290 trades below its calculated fair value: price 9,970 KRW, fair value 28,218 KRW, a gap of about +183% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 018290?
No. The price is what the market pays today (9,970 KRW); the fair value is what the company's own numbers justify (28,218 KRW). For VT GMP Co.Ltd the two are 18,248 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is VT GMP Co.Ltd worth?
The market values VT GMP Co.Ltd at about 351B KRW (market capitalisation, as of Nov 12, 2026). Per share that is 9,970 KRW; our models calculate a fair value of 28,218 KRW per share.
What do the bullish and bearish scenarios say about 018290?
Our models span a range for VT GMP Co.Ltd: cautious scenario 18,816 KRW, base 28,218 KRW, optimistic 46,168 KRW per share (as of Nov 12, 2026, price 9,970 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 018290?
VT GMP Co.Ltd trades at a price-to-earnings ratio of 8.8 (as of Nov 12, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 28,218 KRW is built from several models across several years. Median P/E at fiscal year-end, 8 fiscal years (2018 to 2025), reported earnings, FY2025 ex one-offs: 18.6. Other multiples: P/B 1.5, P/S 0.7, EV/EBITDA 4.6.
How solid is the balance sheet of VT GMP Co.Ltd (018290)?
Balance-sheet figures for VT GMP Co.Ltd (as of Nov 12, 2026): return on equity 14.9%, debt of 0.03 per unit of equity. They feed the Quality Score of 66/100, which measures business quality independently of the share price.
How far is 018290 from its 52-week high?
VT GMP Co.Ltd trades at 9,970 KRW, about 58% below its 52-week high of 23,500 KRW and 3% above the low of 9,710 KRW (as of Nov 11, 2026). Distance from the high says nothing about value: that is what the fair value of 28,218 KRW is for.
Which stocks are comparable to VT GMP Co.Ltd?
From the same area (Industrials) we also value GRG Banking Equipment Co, Crane NXT, Co, Shanghai M&G Stationery Inc, XGD Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is VT GMP Co.Ltd stock attractive at the current price?
The data as of Nov 12, 2026: price 9,970 KRW, calculated fair value 28,218 KRW (+183%), Quality Score 66/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 018290 calculated?
We run VT GMP Co.Ltd through 24 models from 7 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 28,218 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0% above its aggregate fair value. VT GMP Co.Ltd currently trades 65% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of VT GMP Co.Ltd (018290)?
The closing price on Nov 11, 2026 was 9,970 KRW. Our model-based fair value is 28,218 KRW, about +183% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with VT GMP Co.Ltd right now?
The price is below even our cautious bear case (18,816 KRW). The market is more pessimistic than our downside scenario. Solid quality (66/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (18,816 KRW to 46,168 KRW) leaves room in how you read the outcome.

Key figures of VT GMP Co.Ltd

How large is the market capitalisation of VT GMP Co.Ltd (018290)?
The market capitalisation of VT GMP Co.Ltd is 351B KRW (≈ $264M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of VT GMP Co.Ltd (018290)?
The price-to-sales ratio of VT GMP Co.Ltd is 0.75 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of VT GMP Co.Ltd (018290)?
Earnings per share at VT GMP Co.Ltd are 1,129 KRW (price ÷ EPS = P/E 8.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of VT GMP Co.Ltd (018290)?
The net margin of VT GMP Co.Ltd is 8.3% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of VT GMP Co.Ltd (018290)?
The return on equity (ROE) of VT GMP Co.Ltd is 14.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of VT GMP Co.Ltd (018290)?
On an EBIT basis the return on assets of VT GMP Co.Ltd is 18.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of VT GMP Co.Ltd (018290)?
The operating margin of VT GMP Co.Ltd is 8.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at VT GMP Co.Ltd (018290)?
Revenue at VT GMP Co.Ltd is growing +18.1% versus a year earlier (3y avg +22.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at VT GMP Co.Ltd (018290)?
Earnings per share at VT GMP Co.Ltd are growing −86.5% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does VT GMP Co.Ltd (018290) carry?
The net debt of VT GMP Co.Ltd is 14.6B KRW (fiscal year 2024, ≈ 0.3 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch VT GMP Co.Ltd in the live analysis

One click puts VT GMP Co.Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.